Simplify Your Supply Chain In The Race To Phase 1

Early-stage development is very complex, and there are several touch points and vendors involved. There are multiple contracts, multiple project management functions, and multiple ways of working. If the various resources are not connected, you can end up with a process that operates like an uncoordinated relay race.

How can you simplify that whole process? How can we go from one discipline to the next as seamlessly as possible? How do we leverage the vertical and horizontal lines to get you where you need to be?

In this webinar, Ian McGroarty, Ph.D., Senior Business Development Executive, API Europe, Thermo Fisher Scientific, and Kevin Kane, Ph.D., Global SME, Thermo Fisher Scientific, share their thoughts and considerations on how to approach clinical development. They discuss recommendations on strategies for API and drug development activities and how they align heading towards First-In-Human through studies conducted through process validation and commercialization.

McGroarty and Kane also share several case studies highlighting the advantages of single-vendor CDMO services and introduce two concepts: Quick to Clinical™ and Quick to Care™.